Ratings CapMan Oyj

Equities

CAPMAN

FI0009009377

Market Closed - Nasdaq Helsinki Other stock markets 11:29:44 2024-04-18 am EDT			5-day change	1st Jan Change
1.908 ^EUR	0.00%		-4.31%	-16.68%

Apr. 15	Faron Pharmaceuticals reappoints former finance chief on interim basis	AN
Apr. 03	Tana Oy announced that it has received funding from CapMan Oyj	CI

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
This company will be of major interest to investors in search of a high dividend stock.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company's "enterprise value to sales" ratio is among the highest in the world.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Investment Management & Fund Operators

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
CAPMAN OYJ	-16.68%	358M		-
PARTNERS GROUP HOLDING AG	-0.82%	35.42B		B
EQT AB	+1.61%	33.18B		B
ONEX CORPORATION	+6.33%	5.45B	-	C
CORPORACIÓN FINANCIERA ALBA, S.A.	+0.10%	3.02B	-	B-
GOLUB CAPITAL BDC, INC.	+9.93%	2.85B		D+
PETERSHILL PARTNERS PLC	+10.85%	2.66B		C-
BRIDGEPOINT GROUP PLC	-17.62%	2.35B		C+
INVESTCORP CAPITAL PLC	+4.52%	1.24B	-	-
RATOS AB	-3.38%	1.02B		B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes